Aim. A novel anti-infective biopolymer implant coating was developed to prevent bacterial biofilm formation and allow on-demand burst release of anti-infective silver (Ag) into the surrounding of the implant at any time after surgery via focused high-energy extracorporeal shock waves (fhESW). Method. A semi-crystalline Poly-L-lactic acid (PLLA) was loaded with homogeneously dissolved silver (Ag) applied onto Ti6Al4V discs. A fibroblast WST-1 assay was performed to ensure adequate biocompatibility of the Ag concentration at 6%. The prevention of early biofilm formation was investigated in a biofilm model with Staphylococcus epidermidis RP62A after incubation for 24 hours via quantitative bacteriology. In addition, the effect of released Ag after fhESW (Storz DUOLITH SD1: 4000 impulses, 1,24 mJ/mm. 2. , 3Hz, 162J) was assessed via optical density of bacterial cultures (Escherichia coli TG1, Staphylococcus epidermidis RP62A, Staphylococcus aureus 6850) and compared to an established electroplated silver coating. The amount of released Ag after the application of different intensities of fhESW was measured and compared to a control group without fhESW via graphite furnace atomic absorption spectrometry (GF-AAS), scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS). Results. The coating with 6% Ag reduced Staphylococcus epidermidis biofilm formation by 99.7% (mean±SD: 2.1×10^5 ± 3,9×10^5 CFU/µL) compared to uncoated controls (6.8×10^7 ± 4.9×10^7 CFU/µL); (p=0.0001). After applying fhESW the commercially available electroplated silver coating did not prevent the growth of all tested bacterial strains. Bacterial growth is delayed with 4% Ag and completely inhibited with 6% Ag in the novel coating, except for a small increase of S. aureus after 17 hours. SEM and EDS confirmed a local disruption of the coating after fhESW. Conclusions. This novel anti-infective implant coating has the potential to prevent bacterial biofilm formation. The on-demand burst release of silver via fhESW could be an adjunctive in the treatment of implant related infection and is of particular interest in the concept of single stage revision surgery

Aim. The use of medical devices has grown significantly over the last decades, and has become a major part of modern medicine and our daily life. Infection of implanted medical devices (biomaterials), like titanium orthopaedic implants, can have disastrous consequences, including removal of the device. For still not well understood reasons, the presence of a foreign body strongly increases susceptibility to infection. These so-called biomaterial-associated infections (BAI) are mainly caused by Staphylococcus aureus and Staphylococcus epidermidis. Formation of biofilms on the biomaterial surface is generally considered the main reason for these persistent infections, although bacteria may also enter the surrounding tissue and become internalized within host cells. To prevent biofilm formation using a non-antibiotic based strategy, we aimed to develop a novel permanently fixed antimicrobial coating for titanium devices based on stable immobilized quaternary ammonium compounds (QACs). Method. Medical grade titanium implants (10×4×1 mm) were dip-coated in a solution of 10% (w/v) hyperbranched polymer, subsequently in a solution of 30% (w/v) polyethyleneimine and 10 mM sodium iodide, using a dip-coater, followed by a washing step for 10 min in ethanol. The QAC-coating was characterized using water contact angle measurements, scanning electron microscopy, FTIR, AFM and XPS. The antimicrobial activity of the coating was evaluated against S. aureus strain JAR060131 and S. epidermidis strain ATCC 12228 using the JIS Z 2801:2000 surface microbicidal assay. Lastly, we assessed the in vivo antimicrobial activity in a mouse subcutaneous implant infection model with S. aureus administered locally on the QAC-coated implants prior to implantation to mimic contamination during surgery. Results. Detailed material characterization of the titanium samples showed the presence of a homogenous and stable coating layer at the titanium surface. Moreover, the coating successfully killed S. aureus and S. epidermidis in vitro. The QAC-coating strongly reduced S. aureus colonization of the implant surface as well as of the surrounding tissue, with no apparent macroscopic signs of toxicity or inflammation in the peri-implant tissue at 1 and 4 days after implantation. Conclusions. An antimicrobial coating with stable quaternary ammonium compounds on titanium has been developed which holds promise to prevent BAI. Non-antibiotic-based antimicrobial coatings have great significance in guiding the design of novel antimicrobial coatings in the present, post-antibiotic era

ZrN-multilayer coating is clinically well established in total knee arthroplasty [1-3] and has demonstrated significant reduction in polyethylene wear and metal ion release [4,5]. The goal of our study was to analyze the biotribological behaviour of the ZrN-multilayer coating on a polished cobalt-chromium cemented hip stem. CoCr28Mo6 alloy hip stems with ZrN-multilayer coating (CoreHip®AS) were tested versus an un-coated version. In a worst-case-scenario the stems with ceramic heads have been tested in bovine serum in a severe cement interface debonding condition under a cyclic load of 3,875 N for 15 million cycles. After 1, 3, 5, 10 & 15 million cycles the surface texture was analysed by scanning-electron-microscopy (SEM) and energy-dispersive x-ray (EDX). Metal ion concentration of Co,Cr,Mo was measured by inductively coupled plasma mass spectroscopy (ICP-MS) after each test interval. Based on SEM/EDX analysis, it has been demonstrated that the ZrN-multilayer coating keeps his integrity over 15 million cycles of severe stem cemented interface debonding without any exposure of the CoCr28Mo6 substrate. The ZrN-multilayer coated polished cobalt-chromium cemented hip stem has shown a reduction of Co & Cr metal ion release by two orders of a magnitude, even under severe stem debonding and high interface micro-motion conditions. ZrN-multilayer coating on polished cobalt-chromium cemented hip stems might be a suitable option for further minimisation of Co & Cr metal ion release in total hip arthroplasty. Clinical evidence has to be proven during the next years

Aim. To develop a new system for antibacterial coating of joint prosthesis and osteosynthesis material. The new coating system was designed to release gentamicin immediately after insertion to eradicate surgical contamination. Method. Steel implants (2×15mm) were coated with a solid nanocomposite xerogel made from silica and the dendritic polymer, hyperbranched polyethyleneimine. The xerogel was anchored inside a porous surface made by pre-coating with titanium microspheres. Finally, gentamicin was encapsulated in the xerogel, i.e. no chemical binding. A total of 50 µg gentamicin was captured into each implant. The efficacy of the new coating was evaluated in a porcine model of implant associated osteomyelitis. In total, 30 female pigs were randomized into 3 study groups (n=10). Group A; plain implants + saline, Group B; plain implants + 10. 4. CFU of Staphylococcus aureus, and Group C; coated implants + 10. 4. CFU of S. aureus. Implant + inoculum was placed into a pre-drilled implant cavity of the right tibia and the pig was euthanized 5 days afterwards. Postmortem microbiology and pathology were performed. Two additional pigs were used in a pharmacokinetic study where microdialysis (MD) catheters were placed alongside coated implants. Extracellular fluid was sampled regularly for 24 hours from the MD catheters and analyzed for gentamicin content. Results. Within Groups A and C, all implants were found sterile by sonication and bacteria could not be identified within the surrounding bone tissue. In contrast, all Group B animals had S. aureus positive implant and tissue microbiology. Macroscopic and microscopic pathological examinations confirmed that Group A and C animals were complete identic, i.e. no pus around implants and only minor peri-implant inflammation related to insertion of implants per se. All Group B animals had pus around their implants and a massive peri-implant inflammatory response dominated by neutrophil granulocytes. Maximum gentamicin release (35 µg /mL) was measured in the first obtained MD sample, i.e. after 30 min, and the concentration stayed above the MIC level for the used S. aureus strain for 8 hours. Conclusions. The new xerogel coating prevented development of osteomyelitis. Prevention was due to a fast gentamicin release immediately following insertion and antimicrobial active concentrations were detectable several hours after implantation. This means that the critical time point of most relevant surgical procedures potentially could be protected by the novel coating. The new coating will be investigated on larger scale implants and full-size prosthesis in the future

Introduction. To evaluate the effect of hydroxyapatite coating, two same shape cementless stems were compared in this randomized control trial study. Methods. Between May 2003 and February 2010, 88 patients had a primary cementless total hip arthroplasty with two different types of cementless stems. Forty-three patients had Proarc stems (P group) (Kyocera Medical, Osaka, Japan), and Forty-five patients had Proarc HA stems (HA group) (Kyocera Medical, Osaka, Japan) which was coated with thin (20 micrometer) hydroxyapatite on Proarc rough porous coating. Gender distribution, average age at surgery, average weight and average follow-up period were same in the two groups. The average follow-up period was 8.5 years (range, 5 to 13 years). The average age at the time of surgery was 63 years. Porous acetabular shells and highly crosslinked polyethylene liners made by Kyocera Medical corporation were implanted into all hips. Stems were implanted with a modified Hardinge surgical approach without trochanteric osteotomy. Harris Hip Score was used for clinical evaluation. Post-op radiographs of these patients were evaluated. Fisher's exact probability test was used for statistical analysis. P values of less than 0.05 were considered to be significant. Results. The mean preoperative score and postoperative score of P group were 39 points and 86 points, respectively. The mean preoperative score and postoperative score of HA group were 46 points and 87 points, respectively. All stems were evaluated as bone-ingrown fixation in both groups. The rate of varus inclination was not different between two groups. The rate of severe stress shielding was not different. Discussion. However hydroxyapatite coating is useful for early fixation, the adverse effect, such as delamination for long-term in vivo situation is questionable. There was no significant difference between P-group and HA group in the present study. Longer follow-up is required to evaluate hydroxyapatite coating

Introduction. Although cementless press-fit femoral total knee arthroplasty (TKA) components are routinely used in clinical practice, the effect of the interference fit on primary stability is still not well understood. Intuitively, one would expect that a thicker coating and a higher surface roughness lead to a superior fixation. However, during implant insertion, a thicker coating can introduce more damage to the underlying bone, which could adversely influence the primary fixation. Therefore, in the current study, the effect of coating thickness and roughness on primary stability was investigated by measuring the micromotions at the bone-implant interface with experimental testing. Methods. A previous experimental set-up was used to test 6 pairs of human cadaveric femurs (47–60 years, 5 females) implanted with two femoral component designs with either the standard e.motion (Total Knee System, B. Braun, Germany) interference fit of 350 µm (right femurs) or a novel, thicker interference fit of 700 µm (left femurs). The specimens were placed in a MTS machine (Figure 1) and subjected to the peak loads of normal gait (1960N) and squat (1935N), based on the Orthoload dataset for Average 75. Varus/valgus moments were incorporated by applying the loads at an offset relative to the center of the implants, leading to a physiological mediolateral load distribution. Under these loads, micromotions at the implant-bone interface were measured using Digital Image Correlation (DIC) at different regions of interest (ROIs – Figure 1). In addition, DIC was used to measure opening and closing of the implant-bone interface in the same ROIs. Results. After comparing the micromotions and opening of the two implant designs, we found no significant differences between the standard and novel coating. Loading was a significant factor for both opening (P<0.0001) and micromotions (P=0.019), where the squat produced higher micromotions than gait. Opening was seen anteriorly (MA, LA), and was higher during squat. Closing was noticed distally (MD, LD), particularly during gait (Figure 2). During gait (Figure 3), the highest micromotions were found in the posterior condyles (CM, MP), followed by the medial anterior region (MA). For squat, the largest micromotions were in the anterior flange (ANT), followed by the distal regions (LD, MD). Discussion. In the current study, the primary stability of the same implant with two different coating thicknesses was evaluated. The results demonstrate that increasing the coating thickness does not automatically influence the primary stability of a femoral TKA component. This is likely due to abrasion and damage of the underlying trabecular during implant insertion, which also was observed in previous experiments. The exact relation between coating thickness or interference fit and primary implant stability still remains subject to debate. Obviously, the primary implant stability is compromised when the interference fit is too low. However, the current results suggest that there is a threshold beyond which further improvement of the fixation is not possible. The exact magnitude of this threshold is unknown, and may depend on coating characteristics and bone quality, and requires further evaluation, possibly utilizing a hybrid approach of experimental and computational techniques

Introduction. Cobalt chrome femoral head has been used widely in total hip arthroplasty and has shown favorable outcome. However, there is still of concern of potential metal toxicity from the wear debris. In the other hand, titanium is well known for its biocompatibility but it is not used in bearing surface of arthroplasty due to its brittleness. Recently, coating of the prosthesis using plasma electrolytic oxidation (PEO) has shown favorable surface protection. Thus, in this study, we tried to find out whether the PEO coating on the titanium surface would provide surface protection. Materials and methods. Five Titanium alloy (Ti-6Al-4V) ball mimicking femoral head was manufactured and was coted using plasma electrolytic oxidation. Wear rate was tested using validated wear tester with 10N compression force at 80rpm. The amount of wear was detected by measuring change of weight after wear test was completed. This was compared with femoral head manufactured with titanium alloy without PEO coating. Toxicity of the debris was also tested using MTT assay with human osteoblast cell line. Results. Compare to the base titanium metal, PEO coated metal head has shown to provide surface protection. The wear rate has significantly decreased with PEO coating (median value : 0.00015g/mm. 2. vs 0.00006 g/mm. 2. ). MTT assay revealed no cytotoxicity with the amount of debris generated from the wear test. Conclusion. The result of the current study indicate that the PEO coating on the titanium femoral head can significantly decrease the wear rate and is non cytotoxic. This indicates that the femoral head manufactured with titanium alloy and PEO coating maybe a potential alternative to be used in total hip arthroplasty

Periprosthetic joint infections (PJIs) and osteosynthesis-associated infections (OSIs) present significant challenges in trauma and orthopaedic surgery, substantially impacting patient morbidity, mortality, and economic burden. This concern is heightened in patients with pre-existing comorbidities, such as diabetes mellitus, which are not always modifiable at presentation. A novel intraoperative strategy to prevent these infections is the use of Defensive Antibacterial Coating (DAC), a bio-absorbable antibiotic-containing hydrogel applied to implant surfaces at implantation, acting as a physical barrier to prevent infection. The purpose of this study is to assess the use of a commercially available hydrogel (DAC), highlighting its characteristics that make it suitable for managing PJIs and OSIs in orthopaedics and traumatology. Twenty-five patients who underwent complex orthopaedic procedures with intraoperative application of DAC between March 2022 and April 2023 at a single hospital site were included. Post-operative assessment encompassed clinical, laboratory, and radiographic examinations. In this study, 25 patients were included, with a mean age of 70 ± 14.77 years and an average ASA grade of 2.46 ± 0.78. The cohort presented an average Charleston Comorbidity score of 5.45 ± 2.24. The procedures included 8 periprosthetic fractures, 8 foot and ankle surgeries, 5 upper limb surgeries, and 4 elective hip and knee surgeries. Follow-up assessments at 6 weeks and 6 months revealed no evidence of PJI or OSI in any patients, nor were any treatments for PJI or OSI required during the interim period. DAC demonstrated efficacy in preventing infections in high-risk patients undergoing complex orthopaedic procedures. Our findings warrant further investigation into the use of DAC in complex hosts with randomized control trials

Introduction. Cementless arthroplasty has been widely used for younger patients with osteoarthritis and other joint pathology. Cementless arthroplasty will be required to porous surface which is to similar to the trabecular bone for bone ingrowth. Titanium Plasma Spray (TPS) has been worldwide used for the porous coating method on arthroplasty. However, TPS coating is limited that would not to establish optimal porosity for bone ingrowth due to arbitary position of melted powder by plasma gas on substrate. Therefore, it is reported coating detached from its substrate (i.e. arthroplasty) is induced implant loosening. Thus, a novel Laser-aided Direct Metal Tooling (DMT) based on Additive Manufacturing (AM) was developed to overcome these limitations. In this study, we were done to assess stereological analysis, static tensile, shear, abrasion test, and physical analysis for evaluation of the efficacy of DMT which was newly-developed coating technology. Then, mechanical characteristics of DMT coating were compared to commercial TPS coating's. Materials and Methods. First, porosity of the DMT coating was evaluated using Microphotography and Scanning Electron Microscopy (SEM), as described in Figure 1. Static tensile and shear test for assessment of mechanical characteristic in relation to the DMT and TPS coating specimens were conducted on the basis of ASTM F1147 and F1044 using universal testing machine (Endolab®, Servohydraulic Test Frame, DE). Maximum tensile strength and maximum shear strength were evaluated for each specimen (n=5). Abrasion test was performed based on ASTM F1978 using Taber® Rotary Platform Abraser Model 5135 (TABER®Industries, USA). Abrasion losses for each specimen (n=6) were measured at 2, 5, 10, and 100 cycles, respectively. Results. Porosity of the DMT coating was found to be 64 ± 11%. Maximum tensile strength (mean ± SD) of the DMT coating (48.6 ± 4.3 MPa) was lower than TPS's (51.5 ± 11.6 MPa) about 5.6%, but detached position of one of the TPS specimens was observed at coating layer not in adhesive layer. Maximum shear strength of the DMT coating (46.3 ± 1.9 MPa) was 10.2% higher, compared to TPS's (42.0 ± 0.6 MPa). Abrasion losses of the DMT (2 cycles, 1.0 ± 0.5 mg; 5 cycles, 2.5 ± 0.9 mg; 10 cycles, 4.2 ± 0.7 mg; 100 cycles, 20 ± 1.4 mg) were significantly higher (71.9% – 77.8% higher) than that of TPS's (2 cycles, 4.5 ± 1.4 mg; 5 cycles, 9.8 ± 2.8 mg; 10 cycles, 17.0 ± 3.4 mg; 100 cycles, 71.1 ± 4.2 mg), as shown in Figure 2. Roughness of the DMT coating was Ra 62.5 ± 2 μm, Rz 316.1 ± 8.1 μm which were 33.5%, 40.6% (Ra, Rz sequence) higher than that of TPS coating (Ra 46.8 ± 8.9 μm, Rz 224.9 ± 28.8 μm), as shown in Figure 3. Conclusions. Our results suggested that a novel DMT coating technology was feasible to apply coating method on the surface of the arthroplasty in terms of outstanding mechanical characteristics which were compared to commercial TPS coating

The clinical outcome and radiographic analysis of 82 patients undergoing total hip arthroplasty using a titanium acetabular component coated with a new proprietary Titanium Porous Coating inserted without cement are reported. All total hip replacements were performed by a single surgeon and utilized a porous coated, cementless femoral component. Pre clinical testing was carried out in an animal model to evaluate the new porous coating. THR was performed using a cementless acetabular component of the same geometrical design inserted without cement. The component is coated with a new proprietary Titanium Porous Coating wherein the non-spherical bead itself is also porous. This creates a “lava rock” type of structure and gives variability in the pore sizes that aids in the in-growth and apposition of bone (fig 5). The inter-bead pore size: the pore size between each non-spherical bead = 200–525 μm while the Intra-bead pore size: the pore size within each non-spherical bead = 25–65 μm. The resulting surface is extremely rough and provides a robust initial “bite” or “stick” to the bone. Clinical results were evaluated using the Harris Hip score and were recorded prospectively preoperatively and at 6 weeks, 6 months, and 1 year postoperatively. Radiographs were evaluated for component migration, subsidence, and cortical and cancellous biologic response as well as zonal analysis of radiolucent lines, using the Muller THR template. Pre-clinical animal testing of the new porous coating was carried out in 50 sheep using a metacarpal intramedulary implant (similar to a hip stem) designed to function as a Percutaneous Osseointegrated Prosthesis (POP) for amputees and evaluated Apposition Bone Index (ABI) (fig 1), Mineral Apposition Rate (MAR) (fig 2),% Bone In-growth (fig 3), and Axial Pull-out Force (fig 4). Sheep were sacrificed at time points of 0, 3, 6, 9, and 12 months to measure and evaluate the above parameters. Human clinical and radiographic follow up averaged 10.5 months (range 2–18 months). There were 39 females and 43 males. Average age was 59 years. The clinical results were excellent with respect to both pain and function at mid term follow up. Patient satisfaction was high. Radiographic analysis showed no migration or change in the angle of inclination at latest follow up. Femoral component subsidence was detected in 2 cases and averaged 1.8 mm. No polyethylene wear was detected. No hips dislocated. No hips underwent additional surgery. Pre-clinical test data demonstrated excellent mechanical and biological attributes. Average tensile strength of the coating surpassed the FDA minimum requirement by 3X. Animal testing in the sheep showed no evidence of stem loosening or need for revision after 12 months, and corroborated well with clinical results. Correlation between the pre-clinical testing and the human experience was exceptional. Application of a new titanium porous coating utilizing a proprietary dual pore size structure to the surface of the acetabular component provides an extremely rough surface and robust initial fixation during cementless THR. Excellent early clinical and radiographic results are demonstrated. The addition of this new type of porous coating to other arthroplasty components may confer additional clinical advantages

Introduction. Recently, the combination of press-fit acetabular cup with ceramic articulation is a widely used for implanting cementless acetabular components and has been shown to provide good initial stability. However, these methods may lead to elevating stresses, changing in the bearing geometries, and increasing wear due to deformation of the cup and insert. In addition, there is a potential for failure of ceramic inserts when a large ball head was used because it should be assembled with shallow thickness of the acetabular cup. For risk reduction of it, we applied direct metal tooling (DMT) based on 3D printing for porous coating on the cup. Due to its capability of mechanical strength, DMT coated cup could be feasible to provide better stability than conventional coating. Therefore, we constructed laboratory models for deformation test simulating an press-fit situation with large ceramic ball head to evaluate stability of the DMT coated cup compared with conventional coated cup. Materials and Methods. The deformation test was performed according to the test setup described by Z. M. Jin et al. The under reaming of the cavity in a two-point pinching cavity models of polyurethane (PU) foam block (SAWBONES, Pacific Research Laboratories, USA) with a grade 30 were constructed. Titanium plasma spray (TPS) and direct metal tooling (DMT) coated acetabular cups (BENCOX Mirabo and Z Mirabo Cup, Corentec Co. Ltd., KOREA) with a 52 mm size (n=3, respectively) were used for the test. These cups were implanted into the PU foam blocks, and followed by impaction of the inserts (BIOLOX delta, Ceramtec, GE) with a 36/44 size (n=6) into the acetabupar cups as shown in Fig. 1. Roundness and inner diameter of the acetabular cups and inserts were measured using a coordinate measuring machine (BHN 305, Mitutoyo Neuss, GE) in three levels; E2, E3, and E4 (3, 5, and 7 mm below the front face, respectively). Also, these parameters of the acetabular cup were measured in two level; E1 and E5 (5 and 11 mm below the front face) as shown in Fig. 2. Changes in roundness and inner diameter of the cup and insert were measured to evaluate deformation in relation to porous coating on the acetabular cups. Results. Before implantation cups and inserts, roundness and inner diameters were shown good values. When inserts were impacted into the PU foam blocks, there are no significant change in the inner diameters of the cup and insert. However, changes in roundness of the insert which impacted into the DMT coated cup were less deformable than the TPS coated cup's, especially, in E2 level of the inserts (the nearest region of the acetabular rim) as shown in Fig. 3. Conclusions. We demonstrated that deformation of the acetabular cup was affected by the porous coating methods. Although it was limited to few specimens, our results suggested that DMT coated cup would provide more initial stability than TPS coated cup. For figures/tables, please contact authors directly.

Few studies have been reported focusing on developing implant surface nanofiber (NF) coating to prevent infection and enhance osseointegration by local drug release. In this study, coaxial doxycycline (Doxy)-doped polycaprolactone/polyvinyl alcohol (PCL/PVA) NFs were directly deposited on the titanium (Ti) implant surface during electrospinning. The bonding strength of Doxy-doped NF coating on Ti implants was confirmed by a stand single-pass scratch test. The improved implant osseointegration by PCL/PVA NF coatings in vivo was confirmed by scanning electron microscopy, histomorphometry and micro computed tomography at 2, 4 and 8 weeks after implantation. The bone contact surface (%) changes of NF coating group (80%) is significantly higher than that of no NF group (< 5%, p<0.05). Finally, we demonstrated that Doxy-doped NF coating effectively inhibited bacterial infection and enhanced osseointegration in an infected (Staphylococcus aureus) tibia implantation rat model. Doxy released from NF coating inhibited bacterial growth up to 8 weeks in vivo. The maximal push-in force of Doxy-NF coating (38 N) is much higher than that of NF coating group (6.5 N) 8 weeks after implantation (p<0.05), which was further confirmed by quantitative histological analysis and micro computed tomography. These findings indicate that coaxial PCL/PVA NF coating doped with Doxy and/or other drugs have great potential in enhancing implant osseointegration and preventing infection

Introduction. Micro-arc oxidation (MAO) is an electrochemical method used to treat metal surfaces. It provides nanoporous pits, and thick oxide layers, and incorporates calcium and phosphorus into the coating layer of titanium alloy. This modification on the surface of titanium alloy by MAO coating would improve the ability of cementless stems to osseointegrate. In spite of these structural and chemical advantages, clinical study of total hip arthroplasty (THA) using MAO coated stem has not yet been reported. In this study, we evaluated the clinical and radiographic results associated with cementless grit-blasted tapered-wedge stems that were identical in geometry but differed with regard to surface treatment with or without MAO coating. Materials & Methods. We performed a retrospective review of 141 THAs using MAO coated stem for a minimum of 5 years and compared them to 219 THAs using the same geometry stem without MAO coating. A cementless Bencox femoral component (Corentec, Seoul, Korea) was used in all hips. It is made of titanium alloy with a straight, double wedged, tapered stem with a rectangular cross-section. Surface treatment was performed using grit blasting with a roughness of 5.5ųm that was available either with or without MAO coating. Clinical and radiographic evaluations were performed preoperatively and at 6 weeks, 3 months, 6 months, and 1 year postoperatively, and then annually. Results. In the MAO coating group, the mean Harris hip score improved from 43.7 points preoperatively to 93.9 points postoperatively. The mean WOMAC score and UCLA activity score at the final follow-up was 17 points (range, 6–34 points) and 6.9 points (range, 5–10 points), respectively. Thigh pain at final follow-up was reported in 2 hips (1.4%), but neither of these hips showed signs of implant loosening or limited daily activities. Complications included one squeaking, one iliopsoas tendonitis, and one deep vein thrombosis. Postoperative Harris hip scores, WOMAC scores, UCLA activity scores, and complication rates did not differ between the two groups. In both groups, no femoral or acetabular component showed radiographic evidence of mechanical loosening, and no components had been revised at the final follow-up. Conclusions. Primary THA using a cementless grit-blasted tapered-wedge stem with MAO coating showed encouraging medium-term outcomes. Further prospective controlled study is required to investigate the long-term implant survival, possible complications, and cost-effectiveness of utilizing MAO coating in THA

Honey has been used as a topical antiseptic for at least 5,000 years. SurgiHoney is a CE licensed sterile product, which has been proven to be non-toxic and effective when used topically in the treatment of chronically infected wounds. The key difference from other medical grade honey is the broad spectrum antimicrobial characteristics with activity against Gram +ve, Gram –ve and multi-resistant organisms. Its novel role against the bacterial bioburden and biofilm associated with periprosthetic infections around total knee arthroplasties (TKA's) is therefore considered. SurgiHoney was used as an implant coating immediately prior to wound closure after implantation of salvage endoprosthesis for multiply revised, infected TKA's undergoing staged reconstruction. We report a consecutive series of multi-revised, infected revision TKA's where SurgiHoney was used as an active antimicrobial coating. We discuss its intra-operative application and early clinical outcomes. The use of Surgihoney as a novel anti-microbial is established in the management of complex wound infections. This is the first reported use of SurgiHoney as a deep, implant coating in the salvage of prosthetic joint infection

Infection is among the first reasons for failure of orthopedic implants. Various antibacterial coatings for implanted biomaterials are under study, but only few technologies are currently available in the clinical setting. Previous studies showed the in vitro and in vivo efficacy and safety of a fast resorbable (<96 h) hyaluronic and polylactic acid based hydrogel, loaded with antibiotic or antibiofilm agents (DAC®, Novagenit Srl, Mezzolombardo, TN). Aim of this study is to report the results of the largest clinical trial in trauma and orthopedic patients. In this prospective, controlled, study, a total of 184 patients (86 treated with internal osteosinthesis for closed fractures and 98 undergoing cementless total hip or knee joint prosthesis) were randomly assigned in three European orthopaedic centers to receive antibiotic-loaded DAC coating or to a control group, without coating. Pre- and post-operative assessment of laboratory tests, wound healing (ASEPSIS score), clinical score (SF-12 score) and x-rays were performed at fixed time intervals. Statistical analysis was performed with Fisher exact test or Student's t test. Significance level was set at p<0.05. The study was approved by the local Ethical Committee and all patients provided a written informed consent. On average, wound healing, clinical scores, laboratory tests and radiographic findings did not show any significant difference between the two-groups at a mean 12 months follow-up (min: 6, max: 18 months). Four surgical site infections and two delayed union were observed in the control group compared to none in the treated group. No local or systemic side effects, that could be related to DAC hydrogel coating, were noted and no detectable interference with bone healing or osteointegration could be found. This is the largest study, with the longest follow-up, reporting on clinical results after the use of a fast-resosrbable anti-bacterial hydrogel coating for orthopaedic and trauma implants. Our results show the safety of the tested coating in different indications; although not statistically significant, the data also show a trend towards surgical site infection reduction, as previously demonstrated in the animal models

Aim. Aim of this study is to present the first clinical trial on an antibiotic-loaded fast-resorbable hydrogel coating. *. , in patients undergoing internal osteosynthesis for closed fractures. Method. In this prospective, multi-centre, randomized, controlled, prospective study, a total of 260 patients were randomly assigned, in five European orthopaedic centres, to receive the antibiotic-loaded DAC coating or to a control group, without coating. Pre- and post-operative assessment of laboratory tests, wound healing, clinical scores and x-rays were performed at fixed time intervals. Results. 253 patients were available at follow-up. On average, wound healing, clinical scores, laboratory tests and radiographic findings did not show any significant difference between the two-groups. Six early surgical site infections (4.6%) were observed in the control group compared to none in the treated group (p < 0.02). No local or systemic side effects related to DAC hydrogel coating were observed and no detectable interference with bone healing was noted. Conclusions. The use of a fast-resorbable, antibiotic-loaded hydrogel implant coating provides a reduced rate of early surgical site infections after internal osteosynthesis for closed fractures, without any detectable adverse event or side effects

Problems. Biofilm infections are increasingly associated with orthopedic implants. Bacteria form biofilms on the surfaces of orthopedic devices. The biofilm is considered to be a common cause of persistent infections at a surgical site. The growth and the maturation of biofilm are enhanced by the flow of broth in culture environment. In order to reduce the incidence of implant-associated infections, we developed a novel coating technology of hydroxyapatite (HA) containing silver (Ag). We previously reported that the Ag-HA coating inhibits biofilm formation under flow condition of Trypto Soy Broth + 0.25% glucose for 7 days. In this study, we evaluated whether the Ag-HA coating continuously inhibits the biofilm formation on its surface under flow condition of fetal bovine serum, which contains many in vivo substrates such as proteins. Materials and Method. The commercial pure titanium disks were used as substrates. Ag-HA or HA powder was sprayed onto the substrates using a flame spraying system. The HA coating disks were used as negative control. The biofilm-forming methicillin resistant Staphylococcus aureus (BF-MRSA; UOEH6) strain was used. The bacterial suspension (about 10. 5. colony forming units) was inoculated into 24-well sterile polystyrene tissue culture plates. The Ag-HA and HA coating disks were aseptically placed in the wells. After cultivation at 37°C for 1 hour, the disks were rinsed twice with 500 μL sterile PBS (−) to eliminate the non-adherent bacteria. After rinsing, the disks were transferred into petri-dish containing heat-inactivated FBS with a stirring bar on the magnetic stirrer and they were cultured at 37 °C for 24 hours, 7 and 14 days. In the meantime, the stirring bar was spun at 60 rounds per minute. Then, the disks were immersed in a fluorescent reagent to stain the biofilm. Finally, the biofilm on each disk was observed by a fluorescence microscope and the biofilm-covered rate (BCR) on the surfaces of them was calculated using the NIH image software. Results. Biofilm was hardly observed on the Ag-HA coating. However, the biofilm on the HA coating was extensive and mature (Fig. 1). At 24h after cultivation, BCRs of BF-MRSA were 2.1% and 19.8% on the Ag-HA and HA coatings, respectively. Similarly, they were 6.3% and 12.4% on the Ag-HA and HA coatings at 7 days. At 14 days they were 20.6% and 39.4% on the Ag-HA and HA coatings, respectively. These results demonstrate that BCRs on the Ag-HA coating were significantly lower than those on the HA coating (Fig. 2). Discussion. The Ag-HA coating continuously showed the inhibiting ability for biofilm formation under flow condition for 14 days. Ag ions inhibited the biofilm formation on the Ag-HA coating by killing adherent bacteria in the vicinity of the surface, although the release rate of Ag ions was high until 24h after immersion and decreased thereafter. The Ag-HA coating would be expected to contribute to reduction of implant-related biofilm infection

Aim. Infection rates after revision THA vary widely, up to 12%. In countries that use antibiotic-loaded cemented stems in combination with perioperative IV antibiotics, infection rates in registry studies are lower. In many countries, however, cementless revision implants are preferred. Our aim was to apply an antibiotic-loaded calcium sulfate coating to cementless revision stems to reduce periprosthetic joint infection (PJI). This study sought to answer two questions: 1) Does the coating of cementless revision stems with calcium sulfate inhibit osteointegration in THA? 2) Does the antibiotic-loaded calcium sulfate coating of revision stems reduce the incidence of PJI?. Method. From Dec. 2010 to Dec. 2015, 111 consecutive revision femoral stems were coated with commercially pure calcium sulfate. 10cc of calcium sulfate was mixed with 1g of vancomycin powder and 240mg of tobramycin liquid and applied to the stem in a semi-firm liquid state immediately prior to stem insertion. The results are compared to a designated control cohort (N=104) performed across the previous 5 years. The surgical methods were comparable, but for the stem coating. All patients were staged preoperatively using the Musculoskeletal Infection Society Staging System and followed for at least 1 year. Results. In the study group of coated stems, there were 46 A hosts, 56 B hosts, and 9 C hosts. In the control group, there were 45 A hosts, 52 B hosts, and 7 C hosts. Both cohorts had 0 cases of aseptic loosening. The overall rate of PJI in the study cohort was 2.7%. Of the 111 revisions, 69 were aseptic (PJI=1.4%) and 42 were second stage revisions for infection (PJI=4.8%). PJI occurred in 2.2% of A hosts, 1.8% of B hosts, and 11.1% of C hosts. In the control cohort, the overall rate of PJI was 7.7%. Of the 104 revisions, 74 were aseptic (PJI=1.4%) and 30 were second stage revisions for infection (PJI=23.3%). PJI occurred in 6.7% of A hosts, 5.8% of B hosts, and 28.6% of C hosts. The results show a reduction in PJI from 7.7% in the control group to 2.7% in the study group and were found to be statistically significant at p-value<0.1 (p=0.09). Conclusions. The application of antibiotic-loaded calcium sulfate to cementless revision femoral stems does reduce PJI. Importantly, this coating did not inhibit osteointegration of the femoral stem. The reduced infection rate in this study supports the concept that bacteria frequently contaminate and reside within the femoral canal

Introduction. Pin-tract infections are a common problem in orthopaedic surgery, which limits the time an external fixator or Taylor spatial frame can be applied to a patient. The purpose of our study is to evaluate the ability of a novel implant surface coating — cationic steroid antibiotic (CSA)-44 — to delay or prevent the onset of these infections. This coating mimics endogenous antimicrobial peptides of the innate immune system and has been shown to effectively eradicate biofilms as well as prevent infection and stimulate healing of open, contaminated fractures. Methods. Surgeries were performed on 20 animals (outbred; Sprague-Dawley strain rats). Each animal received both CSA-coated and standard-of-care titanium pins, with pins randomized to the fifth or sixth vertebrae prior to surgeries. Animals were also randomized to either “Imaging” (imaging analysis) or “Infection” (microbiological analysis) cohorts. Surgeons were blinded to pin types and analyses cohorts. Digital images of pin sites were collected weekly over 12 weeks, and then graded by two orthopaedic surgery residents according to an established Likert scale. Graders were blinded to animal numbers, pin types, and timepoints (Figure 1). For the infection analysis cohort, four specimens per site were subjected to microbiological analysis from each site (i.e. pin, superficial skin swab, deep skin swab, sonicated bone). Each specimen was processed on three different microbiological plates (i.e. BAP, CAN, MAC) using standardized techniques. Imaging analysis was performed by dissecting vertebrae en bloc with pin retained, followed by fixation in 10% neutral buffered formalin for 72 hours. Following a graded ethanol series and storage in 70% ethanol, specimens were scanned with microcomputed tomography (µCT). Statistical analyses were performed to compare pin site appearance (chi-square testing) as well as total bacterial colony counts within each plate cohort and imaging data (Kruskal-Wallis testing); for all tests, significance was set at α=0.05. Results. Weekly digital images of each pin site were collected, graded, and then averaged (Figure 2). Statistical analysis showed no significant difference in pin appearance between the control and CSA pin cohorts at any timepoints. For the infection analysis cohort, bacterial colonies were counted on BAP, CAN, and MAC plates, followed by bacteria species identification (Figure3). Statistical analysis showed no significant difference in total bacterial colony counts between the control and CSA pin cohorts in any of the plate groups. For the imaging cohort, post-processing and subsequent data and statistical analyses are ongoing. Discussion. No significant differences were found between the control and CSA pin cohorts, with respect to pin appearance during the 12-week study or total bacterial colony counts on three plates, indicating that the control and CSA pins performed equivalently. Imaging analysis is ongoing. Although the environmentally-acquired infection model in an outbred rat strain was used to replicate the onset of pin tract infections in human populations, many animals showed Grade 1 or 2 pin site appearances at the 12-week endpoint. A follow-on study is underway using a direct bacterial seeding model. For any figures or tables, please contact the authors directly

Aim. Infection remains among the first reasons of failure of joint prosthesis. According to various preclinical reports, antibacterial coatings of implants may prevent bacterial adhesion and biofilm formation. Aim of this study is to present the first clinical trial on an antibiotic-loaded fast-resorbable hydrogel coating. *. , in patients undergoing hip or knee prosthesis. Method. In this multi-center, randomized, prospective, study, a total of 380 patients, scheduled to undergo primary or revision total hip or knee joint replacement, using a cementless or a hybrid implant, were randomly assigned, in six European orthopedic centers, to receive the antibiotic-loaded DAC coating or to a control group, without coating. Pre- and post-operative assessment of clinical scores, wound healing, laboratory tests and x-ray were performed at fixed time intervals. Results. Overall 373 patients were available at a minimum follow-up of 6 months (maximum 24 months). On average, wound healing, laboratory tests and radiographic findings did not show any significant difference between the two-groups. Eleven early surgical site infections (6%) were observed in the control group, compared to one (0.6%) in the treated group (p=0.003). No local or systemic side effects related to DAC hydrogel coating were observed and no detectable interference with implant osteointegration was noted. Conclusions. The use of a fast-resorbable, antibiotic-loaded hydrogel implant coating provides a reduced rate of early surgical site infections after hip or knee joint replacement using cementless or hybrid implants, without any detectable adverse event or side effects